HUB Organoids Launches IntegriGut Screen: A Breakthrough Service Offering for Inflammatory Bowel Disease (IBD) Drug Discovery and Development

Featured Story

HUB Organoids Launches IntegriGut Screen: A Breakthrough Service Offering for Inflammatory Bowel Disease (IBD) Drug Discovery and Development

Utrecht, Netherlands – 25th Jan 2024 – HUB Organoids (HUB), a global leader and sole proprietor of patient-derived organoid technology...

Read More

More from HUB

HUB Organoids Announces New Corporate Strategy and Completes Transition from Foundation to Private Company

HUB Organoids Announces New Corporate Strategy and Completes Transition from Foundation to Private Company

[Utrecht, July 18 2023] — HUB Organoids (HUB), the global leader in the field of patient-derived organoids, is excited to...

HUB Organoids extends partnership with Molecular Devices to advance automated intestinal organoid screening technology

HUB Organoids extends partnership with Molecular Devices to advance automated intestinal organoid screening technology

SAN JOSE, Calif., and UTRECHT, Netherlands, Feb. 13, 2023 – Molecular Devices, LLC., a leading provider of high-performance life science...

FDA Modernization Act 2.0: We welcome the dawn of an organoid era

FDA Modernization Act 2.0: We welcome the dawn of an organoid era

X

Have any questions?

contact us